Cargando…
Gut microbiota in patients with obesity and metabolic disorders — a systematic review
BACKGROUND: Previous observational studies have demonstrated inconsistent and inconclusive results of changes in the intestinal microbiota in patients with obesity and metabolic disorders. We performed a systematic review to explore evidence for this association across different geography and popula...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8903526/ https://www.ncbi.nlm.nih.gov/pubmed/35093025 http://dx.doi.org/10.1186/s12263-021-00703-6 |
_version_ | 1784664756642119680 |
---|---|
author | XU, Zhilu JIANG, Wei HUANG, Wenli LIN, Yu CHAN, Francis K.L. NG, Siew C. |
author_facet | XU, Zhilu JIANG, Wei HUANG, Wenli LIN, Yu CHAN, Francis K.L. NG, Siew C. |
author_sort | XU, Zhilu |
collection | PubMed |
description | BACKGROUND: Previous observational studies have demonstrated inconsistent and inconclusive results of changes in the intestinal microbiota in patients with obesity and metabolic disorders. We performed a systematic review to explore evidence for this association across different geography and populations. METHODS: We performed a systematic search of MEDLINE (OvidSP) and Embase (OvidSP) of articles published from Sept 1, 2010, to July 10, 2021, for case–control studies comparing intestinal microbiome of individuals with obesity and metabolic disorders with the microbiome of non-obese, metabolically healthy individuals (controls). The primary outcome was bacterial taxonomic changes in patients with obesity and metabolic disorders as compared to controls. Taxa were defined as “lean-associated” if they were depleted in patients with obesity and metabolic disorders or negatively associated with abnormal metabolic parameters. Taxa were defined as “obesity-associated” if they were enriched in patients with obesity and metabolic disorders or positively associated with abnormal metabolic parameters. RESULTS: Among 2390 reports screened, we identified 110 full-text articles and 60 studies were included. Proteobacteria was the most consistently reported obesity-associated phylum. Thirteen, nine, and ten studies, respectively, reported Faecalibacterium, Akkermansia, and Alistipes as lean-associated genera. Prevotella and Ruminococcus were obesity-associated genera in studies from the West but lean-associated in the East. Roseburia and Bifidobacterium were lean-associated genera only in the East, whereas Lactobacillus was an obesity-associated genus in the West. CONCLUSIONS: We identified specific bacteria associated with obesity and metabolic disorders in western and eastern populations. Mechanistic studies are required to determine whether these microbes are a cause or product of obesity and metabolic disorders. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12263-021-00703-6. |
format | Online Article Text |
id | pubmed-8903526 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-89035262022-03-18 Gut microbiota in patients with obesity and metabolic disorders — a systematic review XU, Zhilu JIANG, Wei HUANG, Wenli LIN, Yu CHAN, Francis K.L. NG, Siew C. Genes Nutr Review BACKGROUND: Previous observational studies have demonstrated inconsistent and inconclusive results of changes in the intestinal microbiota in patients with obesity and metabolic disorders. We performed a systematic review to explore evidence for this association across different geography and populations. METHODS: We performed a systematic search of MEDLINE (OvidSP) and Embase (OvidSP) of articles published from Sept 1, 2010, to July 10, 2021, for case–control studies comparing intestinal microbiome of individuals with obesity and metabolic disorders with the microbiome of non-obese, metabolically healthy individuals (controls). The primary outcome was bacterial taxonomic changes in patients with obesity and metabolic disorders as compared to controls. Taxa were defined as “lean-associated” if they were depleted in patients with obesity and metabolic disorders or negatively associated with abnormal metabolic parameters. Taxa were defined as “obesity-associated” if they were enriched in patients with obesity and metabolic disorders or positively associated with abnormal metabolic parameters. RESULTS: Among 2390 reports screened, we identified 110 full-text articles and 60 studies were included. Proteobacteria was the most consistently reported obesity-associated phylum. Thirteen, nine, and ten studies, respectively, reported Faecalibacterium, Akkermansia, and Alistipes as lean-associated genera. Prevotella and Ruminococcus were obesity-associated genera in studies from the West but lean-associated in the East. Roseburia and Bifidobacterium were lean-associated genera only in the East, whereas Lactobacillus was an obesity-associated genus in the West. CONCLUSIONS: We identified specific bacteria associated with obesity and metabolic disorders in western and eastern populations. Mechanistic studies are required to determine whether these microbes are a cause or product of obesity and metabolic disorders. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12263-021-00703-6. BioMed Central 2022-01-29 /pmc/articles/PMC8903526/ /pubmed/35093025 http://dx.doi.org/10.1186/s12263-021-00703-6 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Review XU, Zhilu JIANG, Wei HUANG, Wenli LIN, Yu CHAN, Francis K.L. NG, Siew C. Gut microbiota in patients with obesity and metabolic disorders — a systematic review |
title | Gut microbiota in patients with obesity and metabolic disorders — a systematic review |
title_full | Gut microbiota in patients with obesity and metabolic disorders — a systematic review |
title_fullStr | Gut microbiota in patients with obesity and metabolic disorders — a systematic review |
title_full_unstemmed | Gut microbiota in patients with obesity and metabolic disorders — a systematic review |
title_short | Gut microbiota in patients with obesity and metabolic disorders — a systematic review |
title_sort | gut microbiota in patients with obesity and metabolic disorders — a systematic review |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8903526/ https://www.ncbi.nlm.nih.gov/pubmed/35093025 http://dx.doi.org/10.1186/s12263-021-00703-6 |
work_keys_str_mv | AT xuzhilu gutmicrobiotainpatientswithobesityandmetabolicdisordersasystematicreview AT jiangwei gutmicrobiotainpatientswithobesityandmetabolicdisordersasystematicreview AT huangwenli gutmicrobiotainpatientswithobesityandmetabolicdisordersasystematicreview AT linyu gutmicrobiotainpatientswithobesityandmetabolicdisordersasystematicreview AT chanfranciskl gutmicrobiotainpatientswithobesityandmetabolicdisordersasystematicreview AT ngsiewc gutmicrobiotainpatientswithobesityandmetabolicdisordersasystematicreview |